Advertisement
Screener

HYPERION DEFI, INC. (HYPD) Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals

1.9 / 5 stars · 19/50 Roast Me

HYPERION DEFI, INC. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals

HYPERION DEFI, INC. (HYPD) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals of $87.12 thousand as of 2025-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals · last filed 2026-03-30

  • 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $87.12K.
Period endDeferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
2025-12-31$87.12K
10-K · filed 2026-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
XBiotech Inc. (XBIT)United States$0.066B-1.56
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76